Skip to main content
Mega Genomics Limited logo

Mega Genomics Limited — Investor Relations & Filings

Ticker · 6667 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 317 across all filing types
Latest filing 2024-12-02 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 6667

About Mega Genomics Limited

https://www.megagenomics.cn

Mega Genomics Limited operates as a genetic testing platform company focused on providing consumer genetic testing and cancer screening services. The core business involves delivering comprehensive genetic analysis solutions to the consumer market. Key product offerings include advanced sequencing packages such as Personal Whole Genome Sequencing, which analyzes over 700,000 genetic loci to assess disease risk and provide pharmacogenomic recommendations. Additionally, the company offers Adult and Children's Whole Exome Sequencing packages, which analyze over 180,000 key exome regions to evaluate risks for high-risk diseases, hereditary cancers, and complex genetic disorders, alongside personalized guidance on drug efficacy, nutrition, and fitness.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is an FF305 “Next Day Disclosure Return” under Hong Kong Main Board and GEM rules, detailing changes in issued shares and treasury shares, including multiple sections on share repurchases (on-market buybacks) and confirmations of compliance. It is not an earnings release, report publication, or governance statement, but specifically a report of transactions in the company’s own shares (share buybacks). This aligns exactly with the “Transaction in Own Shares” category.
2024-12-02 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return under Main Board/GEM rules detailing changes in issued shares, share repurchase transactions (on-market buybacks) and treasury share movements, including number of shares repurchased, prices, and confirmations under listing rules. This is a specific report of the company buying back its own shares (transaction in own shares). Therefore, it fits the ‘Transaction in Own Shares’ category.
2024-11-29 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a formal ‘Next Day Disclosure Return’ (FF305) under the Hong Kong Listing Rules, detailing changes in issued shares and on-market share repurchases (Sections I and II) by the issuer, including number of shares repurchased, repurchase prices, and confirmations. It is not an earnings release, annual report, or management discussion, but a regulatory announcement of share buyback transactions. This fits category 29: Transaction in Own Shares.
2024-11-28 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a regulatory disclosure under the Hong Kong Exchange FF305 "Next Day Disclosure Return" showing detailed on‐market repurchases of shares and treasury share transactions by Mega Genomics Limited, including dates, volumes, prices, and confirmations. This is a direct report of the company’s share buybacks (transactions in its own shares), matching the definition for Transaction in Own Shares (Code: POS).
2024-11-27 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a formal ‘Next Day Disclosure Return’ (Form FF305) under the Hong Kong Listing Rules detailing changes in issued shares and treasury shares, including multiple on-market share repurchases and repurchase mandate details. It is not announcing earnings, management changes, or an annual/interim report but specifically reports the company’s transactions in its own shares (buybacks). This matches the definition for ‘Transaction in Own Shares’ (POS).
2024-11-26 English
Next Day Disclosure Returns
Regulatory Filings
2024-11-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.